186 related articles for article (PubMed ID: 4033630)
1. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
Gurwitz D; Kloog Y; Sokolovsky M
Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
[TBL] [Abstract][Full Text] [Related]
2. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptors in porcine caudate nucleus. I. Enhancement by nickel and other cations of [3H]cis-methyldioxolane binding to guanyl nucleotide-sensitive sites.
Nukada T; Haga T; Ichiyama A
Mol Pharmacol; 1983 Nov; 24(3):366-73. PubMed ID: 6633503
[TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
5. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
[TBL] [Abstract][Full Text] [Related]
6. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
8. Evidence of paired M2 muscarinic receptors.
Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
[TBL] [Abstract][Full Text] [Related]
9. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
Harden TK; Meeker RB; Martin MW
J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
[TBL] [Abstract][Full Text] [Related]
10. Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides.
Gurwitz D; Kloog Y; Sokolovsky M
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3650-4. PubMed ID: 6587380
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
12. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
McMahon KK; Hosey MM
Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
14. Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung.
Bloom JW; Halonen M; Yamamura HI
J Pharmacol Exp Ther; 1988 Feb; 244(2):625-32. PubMed ID: 3346839
[TBL] [Abstract][Full Text] [Related]
15. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
16. Species difference in the muscarinic receptors of thoracic aorta.
Yamanaka K; Hashimoto S; Muramatsu I
J Pharmacol Exp Ther; 1986 Jun; 237(3):980-6. PubMed ID: 3754896
[TBL] [Abstract][Full Text] [Related]
17. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
18. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
Ehlert FJ; Roeske WR; Yamamura HI
J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804
[TBL] [Abstract][Full Text] [Related]
19. Comparison of muscarinic receptor properties in hatched chick heart atrium and ventricle.
Sorota S; Adam LP; Pappano AJ
J Pharmacol Exp Ther; 1986 Mar; 236(3):602-9. PubMed ID: 3754007
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
Brunner F; Kukovetz WR
J Cardiovasc Pharmacol; 1986; 8(4):712-21. PubMed ID: 2427809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
